PCR analyzers for CLIA-waived respiratory PCR testing IHS-SS-26-IHS1520507
Summary
AI-generated · Feb 06, 2026Identify Indian Small Business Economic Enterprises capable of supplying BIOFIRE SPOTFIRE FDA-cleared/authorized, CLIA-waived PCR analyzers for CLIA-waived respiratory PCR testing, with ongoing support for all Oklahoma IHS Laboratories. This is a Buy Indian Act preference exercise to determine capacity and readiness; responses must demonstrate direct capability and experience, and generic statements will not be sufficient.
Submit a capability statement along with the Buy Indian Act Indian Economic Enterprise Representation Form, and include detailed company information (name, socioeconomic status, SAM UEI, DUNS, Cage Code, Tax ID, date, and applicable procurement vehicle), a point of contact with authority to discuss responses, and evidence of SAM registration. Responses should show the ability to provide the specified analyzers and related support, and must be limited to five pages. This is a sources-sought, not a solicitation; providing information is voluntary and does not guarantee a contract, and the Government may use non-proprietary information in future solicitations.
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Pursuant to 48 CFR Part 326, Subpart 326.603-3 and IHM 5.5-6, Indian Health Service must use the negotiation authority of the Buy Indian Act, 25 U.S.C. 47, to give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable. The Government is seeking to identify Indian Small Business Economic Enterprises (ISBEEs) capable of performing the below Indian Health Services (IHS) requirement. Any vendor responding to this notice should submit their capability statement as well as the Buy Indian Act Indian Economic Enterprise Representation Form (attached). Instructions for submission are outlined below. Indian Small Business Economic Enterprises (ISBEEs) and other small business are highly encouraged to respond to this notice. However, firms should understand that generic capability statements are not sufficient for effective evaluation of their capacity and capability to perform the work required. Responses must directly demonstrate the company s capability, experience, and ability to provide BIOFIRE SPOTFIRE FDA-cleared/authorized, CLIA-waived, PCR analyzers for CLIA-waived respiratory PCR testing capability and support for all of the Oklahoma IHS Laboratories. The Government requests interested parties submit a written response to this notice, which includes: a. Company Name. b. Company Socioeconomic Status. c. Company System for Award Management (SAM) Unique Entity Identifier (UEI) number. d. Company point of contact, mailing address, and telephone number(s), and website address e. Name, telephone number, and e-mail address of a company point of contact who has the authority and knowledge to clarify responses with government representatives. f. DUNS Number: g. Cage Code: h. Tax ID i. Date submitted. j. Applicable company GSA Schedule number or other available procurement vehicle. k. Company s System for Award Management (SAM) registration status. All respondents must register on the SAM located at http://www.sam.gov/. l. Submit Indian Health Service Buy Indian Act Indian Economic Enterprise Representation Form (attached) Disclaimer and Important Notes. This notice does not obligate the Government to award contract. Any information provided by industry to the Government as a result of this sources sought synopsis is strictly voluntary. Responses will not be returned. No entitlements to payment of direct or indirect costs or charges to the Government will arise as a result of contractor submission of responses, or the Government's use of such information or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published on a government GPE. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). How to respond: Please include the notice IHS SS-26-IHS1520507 PCR analyzers for CLIA-waived respiratory PCR testing in the subject line. Responses must be submitted via email to the Contract Specialist, Krishna Harriman at krishna.harriman@ihs.gov no later than 11:00 AM EST on February 23, 2026. Capability statements will not be returned and will not be accepted after the due date. The maximum number of pages for this submission is five (5) pages.
From Sources Sought posted on Feb 05, 2026Notice history
1Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA